Le Lézard
Classified in: Science and technology, Business
Subject: ERN

DATABLE TECHNOLOGY CORPORATION ANNOUNCES FINANCIAL RESULTS FOR Q3 2023 AND UPDATE FOR YEAR-TO-DATE 2023


VANCOUVER, BC, Nov. 28, 2023 /CNW/ - Datable Technology Corporation (TSXV: DAC) (OTC Pink: TTMZF) (the "Company" or "Datable" or "DTC"), the developer of a proprietary, SaaS-based Consumer Lifecycle and Data Management Platform called PLATFORM3, is pleased to announce its financial results for the quarter ended September 30, 2023 ("Q3 2023").

For the three-month and nine-month periods ended September 30, 2023, the Company achieved the following milestones:
The Company is also pleased to provide the following 2023 updates:

"We have worked with LMSG to restructure our business by reducing costs and focusing on high-margin SaaS licenses such that we are positioned to drive profitable growth under LMSG," said Robert Craig, Datable's CEO. "The final terms of the definitive agreement with LMSG are expected to include a license for Datable use PLATFORM3  in certain sectors that do not conflict with LMSG, so we are exploring ways to monetize our proven enterprise level software platform."

Results of Operations:

Revenue for the three months ended September 30, 2023 decreased by 36% to $431,048, compared with $678,357 in the same period in 2022 due to a reduction in new annual and long-term licenses signed in 2023 and the corresponding reduced sales and marketing activities in line with cost-cutting. DTC's PLATFORM3 product is an integrated suite of digital marketing applications sold as SaaS for short-term promotions or on an annual subscription basis with recurring revenues. Revenue in the current year reflected recognition of revenue from the previous year's contracts and new sales of the PLATFORM3 product offering.

Gross profit for the three months ended September 30, 2023 decreased by 1% to $240,744, compared to $243,075 in the same period in 2022. Cost of sales for the three months ended September 30, 2023 decreased by 56% to $190,304, compared to $435,282 in the same period in 2022.

Gross margin as a percentage of revenue for the three months ended September 30, 2023 increased by 20% to 56%, compared to 36% in the same period in 2022.  The 20% increase for the three months ended September 30, 2023 was due to an increased percentage of sales from high margin software-as-a-service products. Gross margin depends on the product mix for the reporting period. Revenues are comprised of a combination of higher margin sales of PLATFORM3, the Company's proprietary Software as a Service product, and reward service combined with some lower margin third party services.

General and administrative expenses for the three months ended September 30, 2023 decreased by 14% to $283,393, compared to $330,569 in the same period in 2022. The decrease for the three months ended September 30, 2023 was mainly due to a decrease in corporate consultancy fees, professional fees, investor relations and general administration.

Sales and marketing expenses include wages and salaries, consulting fees, travel expenses, and advertising and licenses. Sales and marketing expenses for the three months ended September 30, 2023 decreased by 47% to $86,373, compared to $163,706 in the same period in 2022. The decrease for the three months ended September 30, 2023 was mainly due to reduction in staff resources and consultants paid in connection with advertising, sales and marketing activities.

Research and development expenditures for the three months ended September 30, 2023 decreased by 58% to $187,932, compared to $449,341 in the same period in 2022. The decrease in research and development expenses for the three months ended September 30, 2023 was related to the reduction in staff and consulting resources while maintaining the quality enhancement to PLATFORM3.  Research and development expense is expected to be significantly lower in 2023 compared to 2022 since the development of the next generation of PLATFORM3 is completed. The enhanced version of PLATFORM3 delivers improved efficiency and reduced implementation cost along with new tools to further monetize first-party consumer data customers.

Net and comprehensive loss for the three months ended September 30, 2023 decreased by 53% to $494,094, compared to $1,050,634 in the same period in 2022. The decrease in net loss for the three months ended September 30, 2023 was mainly due to the reduction of sales and marketing expenses, general and administrative expenses and research and development expenses.

Datable also announces that it has granted 11,275,000 restricted share units ("RSUs") to management and board members under the Company's share compensation plan, subject to approval by the TSXV.

About Datable Technology Corporation

Datable has developed PLATFORM3 a proprietary Consumer Lifecycle and Data Management Platform that is sold to global consumer brands. PLATFORM3 is delivered as a subscription service (Software as a Service model) and used by some of the worlds' most valuable consumer brands to access new consumer communities and engage them while collecting, analyzing, and managing their first-party data. PLATFORM3 incorporates proprietary technology to monetize the consumer data, including demographics and purchasing behaviour, by sending consumers targeted offers by email and text messages.  For more information, visit datablecorp.com.

For additional information about the company please visit www.sedar.com.  The TSX Venture Exchange Inc. has in no way passed upon the merits of the transaction and has neither approved nor disapproved the contents of this press release.  Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.  This news release contains forward-looking information, which involves known and unknown risks, uncertainties and other factors that may cause actual events to differ materially from current expectation. Important factors ? including the availability of funds and the results of financing efforts, ? that could cause actual results to differ materially from the Company's expectations are disclosed in the Company's documents filed from time to time on SEDAR (see www.sedar.com).  Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this press release.  The Company disclaims any intention or obligation, except to the extent required by law, to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.

SOURCE Datable Technology Corp.


These press releases may also interest you

at 21:09
On June 29, the "Gather Great Wisdom to Shape the Future of Intelligent Manufacturing?Special Exhibition on Design Intelligence and High Quality Development", hosted by the China Academy of Art (CAA), opened at the National Museum of China in...

at 20:55
Intermap Technologies ("Intermap" or the "Company"), a global leader in 3D geospatial products and intelligence solutions, announces a new financing. The Company is offering up to a maximum of 4,300,000 Class "A" common shares of the Company...

at 20:45
"The Classic Quotes by Xi Jinping," a multilingual TV show produced by China Media Group, aired in Kazakhstan on Tuesday after Chinese...

at 20:07
Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in discovering, developing and commercializing both first-in-class and best-in-class therapies for hematological malignancies, announced today that on July 2, 2024, in relation to...

at 20:05
Enterprises in Asia Pacific are moving toward software-defined networking (SDN) to make communication more secure and resilient and speed up business decision-making, according to a new research report published today by Information Services Group...

at 20:00
Atara Biotherapeutics, Inc. , a leader in T-cell immunotherapy, leveraging its novel allogeneic Epstein-Barr virus (EBV) T-cell platform to develop transformative therapies for patients with cancer and autoimmune diseases, today announced that Pascal...



News published on and distributed by: